health
Hirsutism Reduction
Hirsutism Reduction refers to a decrease in hirsutism, meaning a reduction in unwanted excess hair growth in women. In practical terms, this outcome concerns whether the amount or appearance of such hair becomes less noticeable over time; it does not necessarily mean complete hair removal.
Hirsutism Reduction describes a specific health outcome. See how this effect is framed in a clear, focused reference.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What may help
None of these options has good evidence yet. Best evidence first.
3 options:3 not enough evidence
AcupuncturepracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a pooled analysis of several trials.
Open the Acupuncture pageMeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a pooled analysis of several trials.
Open the Meditation pageYogapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit. Strongest study: a systematic review of studies.
In people with PCOS, a review reported decreases in mFG scores in two studies: *–1.74 vs *–0.29 and *–1.13 vs *+0.06. The review notes that a decrease in mFG indicates improvement.
Open the Yoga page
The expert view shows every study, dose protocol and source.
What may help
Linked to improving it3 listedStart here
The best we have, but the evidence is still weak
- →PracticesAcupunctureCertaintyLowSourceRCT1 other source
A pooled analysis of randomized trials involving 148 people with PCOS found lower hirsutism scores with acupuncture (MD -2.15 points [-2.71, -1.6]).
Who was studied
- People with a condition
- Pcos
Open AcupunctureStudy result
acupuncture is an efficient method for alleviating hirsutism in patients diagnosed with PCOS (MD: −2.15, 95% CI: −2.71 to −1.6)
- →PracticesMeditationCertaintyLowSourceRCT1 other source
alongside improvements in total testosterone levels and clinical hirsutism
Open MeditationWho was studied
- People with a condition
- Pcos
- →PracticesYogaCertaintyLowSourceClinical1 other source
In people with PCOS, a review reported decreases in mFG scores in two studies: *–1.74 vs *–0.29 and *–1.13 vs *+0.06. The review notes that a decrease in mFG indicates improvement.
Who was studied
- People with a condition
- Pcos
Open YogaStudy result
Mohseni: mFG score *–1.74 vs *–0.29; Nidhi: mFG score *–1.13 vs *+0.06 (decrease in mFG = improvement)
Practices compared
Practices with at least one trial of their own for this goal. Ranked by how sure the evidence is, then effect size.| Practice | How sure | Effect size | Own trials |
|---|---|---|---|
| Acupuncture | CertaintyLowSourceRCT | 1 trial or pooled analysis | |
| Meditation | CertaintyLowSourceRCT | 1 trial or pooled analysis | |
| Yoga | CertaintyLowSourceClinical | 1 trial or pooled analysis |
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Hirsutism Reduction refers to a decrease in hirsutism, meaning a reduction in unwanted excess hair growth in women. In practical terms, this outcome concerns whether the amount or appearance of such hair becomes less noticeable over time; it does not necessarily mean complete hair removal. Research on this outcome has included interventions such as Vitamin E and Berberine, while some proposed approaches remain theoretical rather than supported by human studies.
How interventions help
Interventions linked with hirsutism reduction differ in both their proposed action and the way they were studied. One proposed route is lowering DHT, described for Saw Palmetto. Other findings involve nutrients, plant compounds, or combination products, but the available information does not establish one shared mechanism across them.
The changes reported were assessed after continued use over weeks to months rather than after a single dose. This means the findings describe changes during an intervention period, not necessarily an immediate effect. They also do not establish whether any improvement continues after the intervention is stopped.
The formulation matters. The Glycine finding concerns a product containing 4% capryloyl glycine and 1% glycine soy-fermented extract, so it should not automatically be interpreted as evidence for glycine alone. Similarly, findings for a named ingredient do not necessarily apply to every product containing that ingredient.
The evidence also does not apply uniformly to a defined health status, because the studied health status was not specified. The set includes human studies as well as findings without human evidence, so results should not be generalized across all people with hirsutism. Overall, the reported outcome is a change in hirsutism measures, but the interventions differ substantially in formulation, proposed action, duration of use, and direct relevance to people.
Choosing guidance
When choosing among these options, first separate human evidence from theoretical or anecdotal support. Vitamin E, Berberine, and Glycine have findings from human studies. For Glycine, the result concerns a combination product containing capryloyl glycine and a glycine soy-fermented extract, so it should not automatically be interpreted as evidence for glycine alone. Saw Palmetto and Vitamin B7 (Biotin) do not have human study support for this effect in the information presented; their rationale is theoretical or anecdotal.
The time horizon also differs. Vitamin E and Berberine were assessed over relatively short courses, Glycine over a longer course, and Saw Palmetto over the longest stated period. A longer study period does not mean an effect appears later or that the option is more suitable; it mainly affects how directly the findings apply to someone choosing a short-term versus extended trial. Melatonin is harder to compare across studies because dosing varied.
For readers who prioritize direct human evidence, Vitamin E, Berberine, and the specific Glycine-containing product are the more relevant options to examine first. For readers considering Inositol, Melatonin, or Curcumin, the findings do not provide clear human support for this effect. No listed option has conflicting evidence recorded, but the absence of reported disagreement should not be mistaken for strong or conclusive support.